Cargando…
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
Autoantibodies are increasingly used as biomarkers in the detection of autoimmune disorders and cancer. Disease specific antibodies are generally detected by their binding to specific antigens. As an alternative approach, we propose to identify specific complementarity determining regions (CDR) of I...
Autores principales: | Dekker, Lennard J. M., Zeneyedpour, Lona, Brouwer, Eric, van Duijn, Martijn M., Sillevis Smitt, Peter A. E., Luider, Theo M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018266/ https://www.ncbi.nlm.nih.gov/pubmed/21107826 http://dx.doi.org/10.1007/s00216-010-4361-9 |
Ejemplares similares
-
Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022) -
Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics
por: VanDuijn, Martijn M., et al.
Publicado: (2017) -
Label-free peptide profiling of Orbitrap™ full mass spectra
por: Titulaer, Mark K, et al.
Publicado: (2011) -
A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls
por: Titulaer, Mark K, et al.
Publicado: (2006) -
Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients
por: de Costa, Dominique, et al.
Publicado: (2014)